Viewing Study NCT04481256


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-01-01 @ 4:27 AM
Study NCT ID: NCT04481256
Status: RECRUITING
Last Update Posted: 2024-07-26
First Post: 2020-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 73750
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View